Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
Estring 7.5 microgram/24 hours, vaginal delivery system.
Pharmaceutical Form |
---|
Vaginal delivery system. A slightly opaque ring, made of a silicone elastomer, with a whitish core, containing a drug reservoir of Estradiol Hemihydrate. The product has the following dimensions. Outer diameter – 55 mm; cross sectional diameter – 9 mm; core diameter – 2 mm. |
Each vaginal ring contains: Estradiol Hemihydrate 2.0 mg, corresponding to 1.94 mg estradiol.
Each ring releases estradiol at an average amount of 7.5 microgram per 24 hours, over a period of 90 days.
For the full list of excipients, see section 6.1
Active Ingredient | Description | |
---|---|---|
Estradiol |
Estradiol, is chemically and biologically identical to endogenous human estradiol. It substitutes for the loss of oestrogen production in menopausal women, and alleviates menopausal symptoms. Oestrogens prevent bone loss following menopause or ovariectomy. |
List of Excipients |
---|
Silicone elastomer Q7-4735 A |
Each ring is individually packed in a heat-sealed rectangular pouch consisting of, from outside to inside: Polyester/Aluminium foil/Low density Poly-ethylene. Each pouch is provided with a tear-off notch on one side and is packed into a cardboard carton.
Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
PL 00057/1424
29/07/2013 / 10/07/2018
Drug | Countries | |
---|---|---|
ESTRING | Canada, Spain, Finland, France, Singapore, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.